Drug intelligence / Profile preview

Bupi Qingfei Decoction (Xiyuan Hospital)

Development stage: Unknown
Lead developer: Xiyuan Hospital
Administration: Oral

Overview

Bupi Qingfei Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by Xiyuan Hospital of the China Academy of Chinese Medical Sciences. It is specifically designed for the treatment of bronchiectasis, particularly in patients with *Pseudomonas aeruginosa* colonization. The formula's name reflects its core therapeutic principles in TCM: 'Bupi' (tonifying the spleen) and 'Qingfei' (clearing the lung). By addressing these underlying patterns, the decoction aims to reduce the frequency of acute exacerbations, decrease airway inflammation, and improve the overall quality of life for patients with chronic respiratory infections. It is typically administered as an oral liquid decoction.

Other names: Bupi Qingfei Tang

Beyond the preview

Go deeper on Bupi Qingfei Decoction (Xiyuan Hospital).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bupi Qingfei Decoction (Xiyuan Hospital).

Explore the full profile